Daily non-political popular news in brief.

Mayo Clinic study shows drug-eluting stent use in heart patients determined more by insurance type

If you want the best technology available to relieve blocked blood flow to the heart, the choice is a drug-eluting stent. And you are most likely to obtain the drug-eluting stent for reasons that have nothing to do with your medical condition, a new Mayo Clinic study shows.

Read more »

Keywords: mayo, clinic, study, shows, drug-eluting, stent, heart, patients, determined, insurance, type, show, drug, eluting, patient

« Previous | Next »

Similar news on "Mayo Clinic study shows drug-eluting stent use in heart patients determined more by insurance type":

1. Mayo researchers discover overdiagnosis of long QT heart syndrome
   05-31-2007 · EurekAlert!
   Congenital long QT syndrome can be lethal if not diagnosed -- yet recent increased awareness of the disorder may lead to diagnosing patients when they don't have the syndrome and then prescribing treatments that restrict patients' lifestyles, a new Mayo Clinic study shows.
   Similar news · Read more »
   
2. Mayo researchers: complementary therapies help patients recover after heart surgery
   10-31-2007 · EurekAlert!
   A new Mayo Clinic study shows that massage therapy decreases pain levels for patients after heart surgery.
   Similar news · Read more »
   
3. Bioabsorbable stent shows excellent performance
   03-24-2007 · EurekAlert!
   The use of slow-release drugs in stents (drug-eluting stents) has dramatically reduced restenosis rates after percutaneous coronary intervention. However, these permanent metal devices may impair coronary imaging, predispose patients to late stent thrombosis, prevent positive remodeling and hinder revascularization. A study presented today at the American College of Cardiology's Innovation in Intervention: i2Summit assesses the safety and performance of a bioabsorbable stent that, if effective, could eliminate several of the problems associated with metallic stents.
   Similar news · Read more »
   
4. Mayo Clinic real-time 3-D ultrasound speeds patient recovery
   07-13-2007 · EurekAlert!
   Mayo Clinic physicians have adapted real-time 3-D ultrasound imaging devices -- including one designed to look at an infant's heart -- so that they can watch as they use a needle filled with anesthetic to numb individual nerves located inches under the skin. In this way, they can quickly block nerve function in selected areas of the body prior to surgery, an advance that may spare patients from use of general anesthesia, and sends them home faster and with less need for pain medication.
   Similar news · Read more »
   
5. Test gives insight into prognosis in patients with plasma cell malignancies, finds Mayo Clinic study
   10-24-2007 · EurekAlert!
   A new Mayo Clinic study due to be presented at the annual meeting of the American Society of Human Genetics in San Diego this week shows that a chromosome test called 'FISH' is better than conventional methods in identifying chromosomal genetic abnormalities associated with plasma cell malignancies.
   Similar news · Read more »
   
6. Cryoablation continues to show good results for kidney cancer patients
   11-25-2007 · EurekAlert!
   A review of 62 Mayo Clinic patients who underwent cryoablation to treat cancerous kidney tumors shows that the patients are cancer free for up to two and a half years after having had the procedure.
   Similar news · Read more »
   
7. Mayo Clinic Cancer Center -- Working on the tough cases
   12-11-2006 · EurekAlert!
   Mayo Clinic Cancer Center, in collaboration with researchers from the University of Iowa, today presented results of a Phase II clinical study indicating that an oral drug, tipifarnib, can stall or reverse disease progression for patients with relapsed aggressive non-Hodgkin lymphoma.
   Similar news · Read more »
   
8. 2 drugs equally effective for heart patients undergoing angioplasty, Mayo study finds
   09-10-2007 · EurekAlert!
   In lifesaving procedures to open blocked heart arteries a key question has persisted for years: Is use of the more expensive drug, abciximab, justified over use of the less-expensive eptifibatide?
   Similar news · Read more »
   
9. Mitochondria send death signal to cardiac cells, study shows
   11-08-2007 · EurekAlert!
   Scientists have determined how cardiac cells die just as emergency treatments restore blood flow to a heart in distress, a paradox that has long puzzled doctors who are able to relieve pain in patients suffering from blocked arteries but can't stop the damage caused by the renewed rush of blood. The discovery may lead to new ways to save that dying tissue.
   Similar news · Read more »
   
10. Jefferson scientists find that drug-eluting stents are disappointing in bypass grafts -- sometimes
    03-26-2007 · EurekAlert!
    While drug-eluting stents are effective in keeping open bypassed heart veins that aren’t too diffuse (filled with cholesterol plaque), a new study by cardiologists at Jefferson Medical College shows that they fare less well in keeping open bypassed veins with longer blockages. The researchers suggest that doctors think twice before inserting the drug-coated stents in such extensively diseased bypassed grafts.
    Similar news · Read more »